Literature DB >> 23261186

Smoking topography and outcome expectancies among individuals with schizotypy.

Diana W Stewart1, Christine Vinci, Claire E Adams, Alex S Cohen, Amy L Copeland.   

Abstract

Compared to smokers in the general population, smokers with schizophrenia smoke more cigarettes per day and have higher nicotine dependence and biochemical indicators of nicotine intake. They also have more intense smoking topography and greater positive smoking expectancies. Little is known about the relationship between smoking and schizotypy, defined as the personality organization reflecting a vulnerability to schizophrenia-spectrum pathology. This study assessed schizotypy symptoms, smoking characteristics and behaviors, and smoking expectancies in young adults with psychometrically defined schizotypy and demographically matched controls without schizotypy. Smokers with schizotypy had higher nicotine dependence and smoked more cigarettes per week compared to control smokers. They were also more likely to endorse greater positive consequences (i.e., improved state enhancement, stimulation, social facilitation, taste/sensorimotor manipulation, reduced negative affect and boredom) and fewer negative consequences of smoking. Smokers with schizotypy and control smokers did not differ on smoking topography or carbon monoxide levels. This is the first known study to investigate relationships between these smoking-related variables in smokers with schizotypy. Individuals with schizotypy possessed certain smoking-related characteristics and smoking expectancies similar to those with schizophrenia. This offers preliminary insight into unique smoking-related factors among individuals with schizotypy and highlights the importance of continued research in this area.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23261186      PMCID: PMC3760683          DOI: 10.1016/j.psychres.2012.11.032

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  67 in total

Review 1.  Smoking and schizophrenia.

Authors:  J B Lohr; K Flynn
Journal:  Schizophr Res       Date:  1992-12       Impact factor: 4.939

2.  Why patients smoke.

Authors:  S M Glynn; S Sussman
Journal:  Hosp Community Psychiatry       Date:  1990-09

3.  The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria.

Authors:  A Raine
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

4.  The mortality experience of individuals on the Salford Psychiatric Case Register. I. All-cause mortality.

Authors:  D N Baxter
Journal:  Br J Psychiatry       Date:  1996-06       Impact factor: 9.319

Review 5.  Smoking and vulnerability for schizophrenia.

Authors:  J de Leon
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

6.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

Review 7.  Cigarette smoking: implications for psychiatric illness.

Authors:  A H Glassman
Journal:  Am J Psychiatry       Date:  1993-04       Impact factor: 18.112

Review 8.  The boundaries of schizophrenia.

Authors:  L J Siever; O F Kalus; R S Keefe
Journal:  Psychiatr Clin North Am       Date:  1993-06

9.  Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure.

Authors:  J P Zacny; M L Stitzer; F J Brown; J E Yingling; R R Griffiths
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

10.  Schizophrenia and smoking: an epidemiological survey in a state hospital.

Authors:  J de Leon; M Dadvand; C Canuso; A O White; J K Stanilla; G M Simpson
Journal:  Am J Psychiatry       Date:  1995-03       Impact factor: 18.112

View more
  6 in total

1.  Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.

Authors:  M Garzón; A M Duffy; J Chan; M-K Lynch; K Mackie; V M Pickel
Journal:  Neuroscience       Date:  2013-08-15       Impact factor: 3.590

2.  Clinical Laboratory Evaluation of Electronic Cigarettes/Electronic Nicotine Delivery Systems: Methodological Challenges.

Authors:  Melissa D Blank; Alison B Breland; Caroline O Cobb; Tory Spindle; Carolina Ramôa; Thomas Eissenberg
Journal:  Tob Regul Sci       Date:  2016-10

3.  Electronic Cigarette Expectancies in Smokers with Psychological Distress.

Authors:  Mollie E Miller; Jennifer W Tidey; Damaris J Rohsenow; Stephen T Higgins
Journal:  Tob Regul Sci       Date:  2017-01

4.  Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.

Authors:  A Joseph Bloom; Timothy B Baker; Li-Shiun Chen; Naomi Breslau; Dorothy Hatsukami; Laura J Bierut; Alison Goate
Journal:  Hum Mol Genet       Date:  2013-09-17       Impact factor: 6.150

5.  Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature.

Authors:  Athanasios Gogos; Maria Skokou; Eleni Ferentinou; Philippos Gourzis
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-16       Impact factor: 2.570

6.  Characteristics of Cigarette Smoking in Individuals in Smoking Concordant and Smoking Discordant Couples.

Authors:  Erin M Tooley; Belinda Borrelli
Journal:  Couple Family Psychol       Date:  2017-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.